Author details

Full Name

Donald L Morton

Affiliation

ORCID

Career Start Year

1959

Papers

690

H Index

105

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
29019177	Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.	Annals of Surgical Oncology	2017
26783288	Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.	Clin Cancer Res	2016
26806533	Analysis of the inÂ vivo proliferative capacity of a whole cell cancer vaccine.	Biologicals	2016
25169209	Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.	Pigment Cell Melanoma Res	2015
24968695	DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.	Neuro Oncol	2014
24014427	Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.	Hum Mol Genet	2014
24952441	A 20-year experience of hepatic resection for melanoma: is there an expanding role?	Journal of the American College of Surgeons	2014
24718909	Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis.	Clin Chem	2014
24531700	Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.	Ann Surg Oncol	2014
24904825	Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels.	Frontiers in Oncology	2014
24521106	Final trial report of sentinel-node biopsy versus nodal observation in melanoma.	New England Journal of Medicine	2014
23447565	BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.	Proc Natl Acad Sci U S A	2013
23903435	Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.	JAMA Surgery	2013
23982524	The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.	Nat Rev Clin Oncol	2013
23838920	Age as a prognostic factor in patients with localized melanoma and regional metastases.	Ann Surg Oncol	2013
23643694	Late recurrence in melanoma: clinical implications of lost dormancy.	Journal of the American College of Surgeons	2013
23474948	B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.	J Invest Dermatol	2013
22109733	Staging of regional nodes in pulmonary malignancies.	Annals of Surgical Oncology	2012
22851005	Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread.	Clin Exp Metastasis	2012
22551296	Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".	J Transl Med	2012
22648554	Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).	Annals of Surgical Oncology	2012
22643268	Epitrochlear sentinel lymph nodes in melanoma: interval or independent?	American Surgeon	2012
22293026	Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.	Br J Dermatol	2012
22729520	Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.	Clinical and Experimental Metastasis	2012
22453019	Surgery for distant melanoma metastasis.	Cancer journal (Sudbury, Mass.)	2012
22817889	A landscape of driver mutations in melanoma.	Cell	2012
23008288	Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.	J Clin Oncol	2012
22987185	Preoperative imaging of pulmonary metastases in patients with melanoma: implications for minimally invasive techniques.		2012
22402438	AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.	J Invest Dermatol	2012
23090081	Combined intralesional Bacille Calmette-GuÃ©rin (BCG) and topical imiquimod for in-transit melanoma.	Journal of Immunotherapy	2012
22202581	Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.	Ann Surg	2012
21904216	Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells.	Journal of Immunotherapy	2011
21441044	Management of popliteal sentinel nodes in melanoma.	Journal of the American College of Surgeons	2011
21081840	Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.	Epigenetics	2011
21480255	Unique patterns of metastases in common and rare types of malignancy.	J Surg Oncol	2011
21381040	Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.	Journal of Surgical Oncology	2011
21135695	Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.	Ann Surg	2011
21519009	Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.	J Clin Oncol	2011
20368546	Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.	J Clin Oncol	2010
19587692	Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.	J Invest Dermatol	2010
19774417	Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?	Annals of Surgical Oncology	2010
20482676	The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions.	Journal of Cutaneous Pathology	2010
20614193	The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).	Annals of Surgical Oncology	2010
19968820	High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.	Pigment Cell Melanoma Res	2010
20512942	Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.	Journal of Surgical Oncology	2010
20157080	Predictors of occult nodal metastasis in patients with thin melanoma.	Arch Surg	2010
19903777	Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.	Clinical Cancer Research	2009
19451446	Improved survival for stage IV melanoma from an unknown primary site.	Journal of Clinical Oncology	2009
19223509	CpG island methylator phenotype predicts progression of malignant melanoma.	Clin Cancer Res	2009
19130137	Solitary dermal melanoma: beginning or end of the metastatic process?	Annals of Surgical Oncology	2009